StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Horizon Therapeutics seen worth up to $140/share in takeover
November 30, 2022 8:12 AM
Several Wall Street analysts put pencil to paper after Horizon Therapeutics (NASDAQ: HZNP) said Tuesday evening that it was in ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Hot Comments
Hot List
Mergers and Acquisitions
Rumors
Next Articles
Jefferies sees up to 90% chance Horizon Therapeutics (HZNP) gets acquired, with $125 base case
December 1, 2022 11:06 AM
'Compelling value' in Viridian Therapeutics following Horizon Therapeutics acquisition talks
November 30, 2022 10:39 AM
Horizon Therapeutics (HZNP) option IV into confirms in deal discussions
November 30, 2022 5:49 AM
After-Hours Movers: Horizon Therapeutics Gains on Takeover Talks, CrowdStrike Sinks on EPS
November 29, 2022 5:56 PM
3 Rumors Pushing Around Stocks Today
November 29, 2022 5:41 PM
Horizon Therapeutics (HZNP) jumps after confirming takeover talks with 3 parties
November 29, 2022 5:23 PM
Form 8-K Horizon Therapeutics For: Nov 29
November 29, 2022 5:22 PM
Horizon Therapeutics (HZNP) resumes trading, up 39%
November 29, 2022 4:55 PM
Horizon Therapeutics (HZNP) Confirms Talks on Takeover With Three Large Pharma Cos.
November 29, 2022 4:26 PM
Horizon Therapeutics plc Confirms Preliminary Discussions Regarding Potential Offer
November 29, 2022 4:25 PM
Horizon Therapeutics (HZNP) Fields Takeover Interest - WSJ
November 29, 2022 4:22 PM
